Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 35.7730.8923.5130.6732.80

What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 35.77 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202535.77
Mar202430.89
Mar202323.51
Mar202230.67
Mar202132.80

How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 35.77
15.80
Mar2024 30.89
31.39
Mar2023 23.51
-23.35
Mar2022 30.67
-6.49
Mar2021 32.8 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹49,700.3 Cr -5% -11.1% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-5%

-11.1%

15.6%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses